Schindler Holding AG SCHINDLER HO.../ CH0024638212 /
24/05/2024 18:35:01 | Chg. - | Volume | Bid06:00:04 | Ask06:00:04 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
236.00CHF | - | 1,299 Turnover: 304,417 |
-Bid Size: - | -Ask Size: - | 24.43 bill.CHF | 2.21% | 28.07 |
GlobeNewswire
12/06
The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for...
GlobeNewswire
29/04
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s...
GlobeNewswire
04/01
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel trea...
GlobeNewswire
15/11/2023
UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results
GlobeNewswire
08/11/2023
UCLOUDLINK GROUP INC. to Report Third Quarter 2023 Financial Results on November 15, 2023
GlobeNewswire
18/10/2023
Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical Colleg...
Newsfile Corp
28/06/2022
Controlled Energy Partners Forms Joint Venture Between Strata Exploration Trust & Controlled Capital
GlobeNewswire
20/01/2022
FARMERS AND MERCHANTS BANCSHARES, INC. AND FARMERS AND MERCHANTS BANK ANNOUNCE THE PLANNED RETIREMEN...
GlobeNewswire
21/11/2021
Holiday Season is Off to a Grand Start with Twentieth Annual Festival of Lights at Moody Gardens
GlobeNewswire
17/11/2021
Nufabrx Ranked Number No. 2 in Pharmaceuticals, No. 8 Fastest-Growing Company in North America on th...
GlobeNewswire
29/10/2021
AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika B...
GlobeNewswire
15/09/2021
Innate Pharma Reports First Half 2021 Financial Results and Business Update
GlobeNewswire
17/08/2021
NUFABRX (Textile Based Delivery Inc.) Ranks No. 50 on the 2021 Inc. 5000, With Three-Year Revenue Gr...
GlobeNewswire
19/07/2021
Capital Digestive Care Partners with Colliers & Facility Logix to Expand its Clinical Laboratory Foo...
GlobeNewswire
12/07/2021
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme